MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$5,153K
Net Income
-$5,481K
Net Profit Margin
-106.37%
EPS
-$0.31
Unit: Thousand (K) dollars
Revenue Breakdown
Sleep Testing Services
Revenue From Contract With Custo...
Treatment Centers
Others
Revenue Breakdown
Sleep Testing Services
Treatment Centers
Tooth Positioners
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenue
5,153
5,141
3,824
6,783
Cost of sales (exclusive of depreciation and amortization shown separately below)
2,200
2,082
838
2,846
Gross profit
2,953
3,059
2,986
3,937
General and administrative
7,113
8,971
8,542
7,884
Sales and marketing
155
249
379
403
Depreciation and amortization
510
454
442
384
Total operating expenses
7,778
9,674
9,363
8,671
Operating loss
-4,825
-6,615
-6,377
-4,734
Other expense
-1,050
-1,167
-635
-679
Other income
352
31
59
13
Loss before income taxes
-5,523
-7,751
-6,953
-5,400
Net loss
-5,523
-7,751
-6,908*
-
Net loss attributable to non-controlling interest
-42
-69
-15*
-
Net loss attributable to stockholders
-5,481
-7,682
-6,893
-5,400
Basic EPS
-0.31
-0.52
-0.554
-0.49
Diluted EPS
-0.31
-0.52
-0.554
-0.49
Basic Average Shares
17,681,945
14,634,115
12,449,444
10,963,590
Diluted Average Shares
17,681,945
14,634,115
12,449,444
10,963,590
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
1
2
Net loss
attributable to stockholders
-$5,481K
(-9.34%↓ Y/Y)
Net loss
attributable to...
-$42K
Sleep Testing
Services
$2,392K
(183.41%↑ Y/Y)
Treatment Centers
$767K
Myofunctional Therapy
Services
$337K
(106.75%↑ Y/Y)
Sponsorship Seminar Other
$161K
(-73.52%↓ Y/Y)
Billing Intelligence
Services
$129K
(-32.11%↓ Y/Y)
VIP
$12K
(-90.77%↓ Y/Y)
Revenue From Contract
With Customer...
$1,355K
(-28.12%↓ Y/Y)
Net loss
-$5,523K
(-10.17%↓ Y/Y)
Service
$3,798K
(96.28%↑ Y/Y)
Product
$1,355K
(-28.12%↓ Y/Y)
Loss before income
taxes
-$5,523K
(-10.17%↓ Y/Y)
Other income
$352K
(2246.67%↑ Y/Y)
Total revenue
$5,153K
(34.90%↑ Y/Y)
Operating loss
-$4,825K
(0.82%↑ Y/Y)
Other expense
-$1,050K
(-544.17%↓ Y/Y)
Gross profit
$2,953K
(39.95%↑ Y/Y)
Cost of sales
(exclusive of depreciation...
$2,200K
(28.65%↑ Y/Y)
Total operating
expenses
$7,778K
(11.51%↑ Y/Y)
General and
administrative
$7,113K
(10.98%↑ Y/Y)
Depreciation and
amortization
$510K
(66.67%↑ Y/Y)
Sales and marketing
$155K
(-40.38%↓ Y/Y)
Buy us a coffee
Vivos Therapeutics, Inc. (VVOS)
Vivos Therapeutics, Inc. (VVOS)